Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2026 09:00 ET | Source: KALA BIO, Inc.

Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate

AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio’s purpose-built agentic AI platform for the biotechnology industry TORONTO...
March 18, 2026 08:00 ET | Source: VIRAL VECTOR MANUFACTURING FACILITY PTY. LTD.

Viral Vector Manufacturing (VVMF) enters into licensing agreement with OXB, gaining access to the OXB AAV and LV viral vector platforms

Australia's only viral vector CDMO, Viral Vector Manufacturing Facility Pty Ltd (VVMF), enters into a licensing and option agreement with OXB (LSE:OXB).
March 17, 2026 08:30 ET | Source: PolyPid Ltd.

PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application

FDA Grants $4.3 Million Small Business Waiver, Enabling Focus on Commercialization Preparations Company On Track to Initiate NDA Submission by the End of this Month PETACH TIKVA, Israel, March 17,...
March 17, 2026 08:00 ET | Source: 1606 CORP.

1606 Corp. Signs Agreement to Acquire Data-Center-Ready Property with Captive Power on 132 Acres

1606 Corp. Signs Agreement to Acquire Data-Center-Ready Property with Captive Power on 132 Acres
March 16, 2026 07:30 ET | Source: Zevra Therapeutics

Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million

BOSTON, March 16, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare...
March 11, 2026 09:04 ET | Source: KOMO Biosciences, Inc

KOMO Biosciences Grants Research Evaluation License to Syngenta to Explore Precision Genome Modification in Maize

KOMO Biosciences announced that it has granted Syngenta , a Research Evaluation License to assess aspects of KOMO’s proprietary KOMbine™ platform.
March 11, 2026 08:00 ET | Source: Adeia Inc.

Adeia and UMC Expand Long-Term Collaboration in Hybrid Bonding Technologies

Adeia and UMC Expand Long-Term Collaboration in Hybrid Bonding Technologies
March 10, 2026 09:30 ET | Source: VEON Ltd.

VEON’s Largest Market Pakistan Almost Triples Mobile Spectrum in Reform Push; Jazz Secures Largest Allocation with 190 MHz

Islamabad, Dubai and New York - March 10, 2026: VEON Ltd. (Nasdaq: VEON, “VEON”), a global digital operator, is pleased to note the successful mobile spectrum auction held today in its largest market...
March 10, 2026 09:00 ET | Source: EnWave Corporation

EnWave Signs License Agreement, and Equipment Purchase Agreement with Teagasc, the Agricultural and Food Development Authority of Ireland

VANCOUVER, British Columbia, March 10, 2026 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it has signed a license agreement (the...
March 10, 2026 08:30 ET | Source: Celularity Inc.

Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy

Transaction expected to generate up to $35 million in upfront and milestone paymentsCelularity retains exclusive manufacturing rights, creating continued biomaterials revenue and margin...